---
document_datetime: 2023-09-21 17:05:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tagrisso-epar-all-authorised-presentations_en.pdf
document_name: tagrisso-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8841675
conversion_datetime: 2025-12-14 22:12:43.441674
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number        | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------|
| EU/1/16/1086/001 | TAGRISSO          | 40 mg      | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 30 x 1 tablets (unit dose) |
| EU/1/16/1086/002 | TAGRISSO          | 80 mg      | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 30 x 1 tablets (unit dose) |
| EU/1/16/1086/003 | TAGRISSO          | 40 mg      | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 28 x 1 tablets (unit dose) |
| EU/1/16/1086/004 | TAGRISSO          | 80 mg      | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 28 x 1 tablets (unit dose) |